HRMY vs DBVT vs PRGO vs IQV

For growth investors, Harmony Biosciences Holdings, Inc.

(HRMY) is the stronger pick with 21. 5% revenue growth year-over-year, versus -2. 8% for Perrigo Company plc (PRGO). Harmony Biosciences Holdings, Inc. (HRMY) offers the better valuation at 11. 6x trailing P/E (9. 0x forward), making it the more compelling value choice. Analysts rate Harmony Biosciences Holdings, Inc. (HRMY) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Harmony Biosciences Holdings, Inc.

(HRMY) is the cheapest at 11. 6x versus IQVIA Holdings Inc. at 22. 8x. On forward P/E, Perrigo Company plc is actually cheaper at 5. 6x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Harmony Biosciences Holdings, Inc.

(HRMY) delivered a total return of +13. 3%, compared to -69. 1% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: IQV returned +166. 5% versus DBVT's -87. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Harmony Biosciences Holdings, Inc.

(HRMY) is the lower-risk stock at 0. 79β versus IQVIA Holdings Inc. 's 1. 33β — meaning IQV is approximately 69% more volatile than HRMY relative to the S&P 500. On balance sheet safety, DBV Technologies S. A. (DBVT) carries a lower debt/equity ratio of 13% versus 2% for IQVIA Holdings Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Harmony Biosciences Holdings, Inc.

(HRMY) is pulling ahead at 21. 5% versus -2. 8% for Perrigo Company plc (PRGO). On earnings-per-share growth, the picture is similar: Harmony Biosciences Holdings, Inc. grew EPS 8. 0% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, HRMY leads at 25. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Harmony Biosciences Holdings, Inc.

(HRMY) is the more profitable company, earning 18. 3% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps 18. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HRMY leads at 24. 0% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — HRMY leads at 77. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Perrigo Company plc (PRGO) trades at 5.

6x forward P/E versus 14. 1x for IQVIA Holdings Inc. — 8. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DBVT: 131. 8% to $46. 33.

In this comparison, PRGO (9.

8% yield) pays a dividend. HRMY, DBVT, IQV do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Perrigo Company plc (PRGO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

18), 9. 8% yield). Both have compounded well over 10 years (PRGO: -77. 7%, DBVT: -87. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: HRMY is a small-cap high-growth stock; DBVT is a mega-cap quality compounder stock; PRGO is a small-cap income-oriented stock; IQV is a mid-cap quality compounder stock. PRGO pays a dividend while HRMY, DBVT, IQV do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.